4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-016941
Chief Medical Officer sold 17,500 shares at an average $22.17 ($388,000)
- Chief Medical Officer acquired 17,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-03-01 | Option exercise | +5,775 | $5.28 | $30,492 | 5,775 | D |
| Ho Carole Chief Medical Officer | 2019-03-01 | Sale | −3,824 | $22.17 | $84,778 | 1,951 | D |
| Ho Carole Chief Medical Officer | 2019-03-01 | Sale | −1,951 | $22.92 | $44,717 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-03-04 | Option exercise | +5,863 | $5.28 | $30,957 | 5,863 | D |
| Ho Carole Chief Medical Officer | 2019-03-04 | Sale | −4,263 | $21.87 | $93,232 | 1,600 | D |
| Ho Carole Chief Medical Officer | 2019-03-04 | Sale | −1,600 | $22.84 | $36,544 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-03-05 | Option exercise | +5,862 | $5.28 | $30,951 | 5,862 | D |
| Ho Carole Chief Medical Officer | 2019-03-05 | Sale | −5,862 | $21.96 | $128,730 | 0 | D |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-03-01 | Option exercise · Stock Option (right to buy) | −5,775 | 123,855 | D | ||
| Ho Carole Chief Medical Officer | 2019-03-04 | Option exercise · Stock Option (right to buy) | −5,863 | 117,992 | D | ||
| Ho Carole Chief Medical Officer | 2019-03-05 | Option exercise · Stock Option (right to buy) | −5,862 | 112,130 | D | ||
| Open-market sales · 17,500 sh · avg $22.17 · $388,000 | |||||||
Loading xslF345X03/doc4.xml…